Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating income | -$9.65M | -$19.2M | -$30.9M | -$56.2M | -$80.0M | -$118M | -$177M | -$235M | -$262M | -$320M |
| Net income | -$7.70M | -$19.7M | -$30.8M | -$52.6M | -$80.9M | -$118M | -$174M | -$216M | -$247M | -$314M |
| EPS (diluted) | -$1.55 | -$3.96 | -$1.33 | -$1.54 | -$1.75 | -$2.26 | -$2.99 | -$3.24 | -$3.07 | -$3.38 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.08M | -$16.0M | -$25.4M | -$60.6M | -$61.4M | -$82.2M | -$128M | -$185M | -$192M | -$280M |
| Capital expenditures | $238K | $136K | $2.60M | $6.54M | $2.39M | $2.34M | $2.27M | $5.66M | $6.69M | $4.22M |
| Free cash flow | -$7.32M | -$16.1M | -$28.0M | -$67.1M | -$63.8M | -$84.5M | -$130M | -$191M | -$199M | -$285M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $20.7M | $17.6M | $25.7M | $59.5M | $183M | $106M | $147M | $74.5M | $111M | $209M |
| Total assets | — | $65.2M | $154M | $234M | $543M | $461M | $647M | $488M | $551M | $332M |
| Total liabilities | — | $6.86M | $16.5M | $50.4M | $44.4M | $50.0M | $91.3M | $113M | $135M | $166M |
| Long-term debt | — | — | — | $9.80M | — | $0.00 | $28.6M | $44.8M | $46.4M | $83.3M |
| Shareholders' equity | -$11.5M | -$28.1M | $138M | $184M | $499M | $411M | $555M | $375M | $416M | $166M |
| Retained earnings | — | -$28.9M | -$59.8M | -$112M | -$193M | -$311M | -$485M | -$701M | -$949M | -$1.26B |
| Shares (wtd avg diluted) | — | 5.01M | 31.7M | 36.7M | 46.2M | 52.2M | 58.2M | 66.6M | 80.6M | 92.8M |
Every figure is extracted from Replimune Group, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.